HK-ZFN-AURKB-mEGFP Cells

Unit

3 x 10^6 cells/ml

Cell Type

Stable (KO/Expressing) Cells

Tissue Type

Reporter-labeled cells

Organism

Human

Donor History

Adenocarcinoma

Growth Properties

Adherent

Growth Conditions

Culture medium: DMEM

,

w: 4.5 g/L Glucose

,

w: 4 mM L-Glutamine

,

w: 3.7 g/L NaHCO3

,

w: 1.0 mM Sodium pyruvate (Cytion article number 820300a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/HK-ZFN-AURKB-mEGFP-Cells/300173

Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The HK-ZFN-AURKB-mEGFP cell line is a genetically engineered human cell model designed to express the AURKB (Aurora Kinase B) protein fused with mEGFP (monomeric Enhanced Green Fluorescent Protein) using Zinc Finger Nuclease (ZFN) technology. AURKB is a serine/threonine kinase that plays a crucial role in mitotic chromosome segregation, cytokinesis, and the regulation of the mitotic spindle checkpoint. The fusion with mEGFP allows for real-time visualization of AURKB activity and localization within the cell, facilitating detailed studies of its dynamic behavior during cell division.
This cell line serves as a powerful tool for researchers investigating the molecular mechanisms of mitosis and the specific functions of AURKB. The incorporation of mEGFP enables fluorescence-based assays and live-cell imaging, providing insights into the spatiotemporal distribution of AURKB. The use of ZFN technology ensures precise genomic integration, maintaining the fidelity of AURKB expression. This model is particularly valuable in cancer research, where AURKB is often overexpressed and linked to tumorigenesis, making it a potential target for therapeutic interventions.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.